Test Price
850 AED✅ Home Collection Available
Respiratory Panel 8 Test in UAE | 850 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection for throat/nasal swabs and sputum; BAL requires hospital setting. Available daily 8 AM – 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Compliance: Fully compliant with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning Use of ICT in Health Fields.
Test Overview & Methodology
The Respiratory Panel 8 Test simultaneously detects eight common respiratory pathogens (influenza A/B, RSV, SARS‑CoV‑2, adenovirus, and others) from a single throat/nasal swab, sputum, or BAL sample using high‑sensitivity real-time PCR. Results are available within 48 hours, enabling precise antiviral or supportive therapy and reducing unnecessary antibiotic use.
| Feature | Our Respiratory Panel 8 Test | Closest Alternative (4-Pathogen Rapid Antigen Kit) |
|---|---|---|
| Method | Real‑Time PCR (qPCR) – gold standard molecular detection | Rapid Antigen Lateral Flow |
| Targets | 8 pathogens: flu A, flu B, RSV, SARS‑CoV‑2, adenovirus, parainfluenza 1–3, human metapneumovirus | 4 pathogens (typically flu A/B, RSV, SARS‑CoV‑2 only) |
| Turnaround | 48 hours from sample collection | 15–30 minutes (point-of-care) |
| Sensitivity | ~99% analytical sensitivity | ~80–90% (high false-negative risk) |
Physician Insight & Safety Protocols
“As a practicing physician, I advise that the Respiratory Panel 8 test provides rapid molecular identification of viral and some bacterial pathogens; however, clinical correlation with symptoms, exposure history, and local epidemiology remains essential. Laboratory results do not replace full clinical evaluation, so do not hesitate to discuss results with your doctor.”
— Dr. Ajay Singh, General Practitioner, DHA License: 36234132
Safety Exclusion Criteria & Red Flags
- Patients with severe acute respiratory distress (SpO₂ < 92% on room air) or hemodynamic instability should seek emergency care immediately – do not wait for test results.
- Home collection is not advised for patients with active bleeding diathesis or those requiring continuous positive airway pressure (CPAP) that cannot be interrupted.
- If you experience severe shortness of breath or chest pain, proceed immediately to the nearest emergency department.
Important Medication Notice
Do not discontinue prescribed medication without consulting your doctor. Stopping medications without medical advice can be dangerous; continue all treatments as directed and discuss any concerns with your physician after receiving the results.
Patient FAQ & Clinical Guidance
1. What does the Respiratory Panel 8 test detect?
Our PCR panel accurately identifies eight respiratory pathogens—including influenza A/B, RSV, SARS‑CoV‑2, and adenovirus—from a single throat or nasal swab sample, enabling precise antiviral or supportive therapy within 48 hours.
2. How is the sample collected, and is home collection available?
A trained phlebotomist comes to your home (8 AM–11 PM) using an ISO‑certified cold‑chain for throat/nasal swabs or sputum; BAL samples require a hospital setting. You will receive your digital report within 48 hours, with results explained by our clinical team.
3. Should I stop my current medications before this test?
Stopping prescribed medications without medical advice can be dangerous; continue all treatments as directed and discuss any concerns with your physician after receiving the results.
4. Is the test safe for children and pregnant women?
Yes, the throat/nasal swab is minimally invasive and safe for all ages. However, please inform the phlebotomist if you are pregnant or have any bleeding disorders. Parental consent is required for minors in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
This test and associated data processing comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring patient data confidentiality and secure handling.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the use of health data and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical safety.
All samples are processed at DNA Labs UAE, a DHA-licensed facility (License No. 1143) under strict ISO quality standards.
Clinical & Logistical Metadata
| Test Name | Respiratory Panel 8 (Real-Time PCR) |
| Price (AED) | 850 AED |
| Turnaround Time | 48 hours from sample collection |
| Sample Type / Matrix | Throat/Nasal swab, sputum; BAL requires hospital setting |
| Methodology Used | Real-Time PCR (qPCR) |
| ICD-10-CM Code | J00 (Acute nasopharyngitis), J22 (Unspecified acute lower respiratory infection) |
| LOINC Code | 60568-4 (Respiratory pathogens DNA and RNA panel) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians